Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol vs Propofol Anesthesia for ECT in Depression
NCT05266560Phase 1Unknown
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Mar 2022
- Primary completion
- Jul 2024
- Modality
- Allosteric Modulators
01
Overview
Phase 1, randomised trial of ciprofol in major depressive disorder (MDD) (2 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoint: Cognitive impairment rate within 24 hours after the whole ECT course. Status: unknown.
02
Drugs
ciprofol
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05266560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05266560.